Pfizer slid in premarket trading as Oxford study found two vaccine doses wouldn’t protect from Omicron infection

Tiger Newspress2021-12-14

Pfizer slid in premarket trading asOxford study found two vaccine doses wouldn’t protect from Omicron infection.A new study from researchers at the University of Oxford has found two doses of either the Pfizer or AstraZeneca COVID-19 vaccine may not be enough to protect against infection from the Omicron variant. The data offers no indication of protection from severe disease, but shows two doses will not be enough to prevent Omicron infection in most people.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • princejumong
    2021-12-16
    princejumong
    Maybe every 6 mths we hv to boost. As its effect will wane [sick] 
  • Handoko
    2021-12-14
    Handoko
    😎
  • Txfen80
    2021-12-14
    Txfen80
    what’s new? how many more shots? how frequent we need?
  • Wkmk
    2021-12-14
    Wkmk
    3 best for now
  • Stripey
    2021-12-14
    Stripey
    Contradicting news. One article says there is effect and another no
  • Go4good
    2021-12-14
    Go4good
    2 doses not enough, will it mean more booster? 🤔
发表看法
21